Closure Medical

Closure Medical Corporation was a pioneering medical device company based in Raleigh, North Carolina, that specialized in the development of medical adhesives and sealants. The company's core technology was based on proprietary cyanoacrylate formulations, which led to the creation of Dermabond, the first topical skin adhesive approved by the FDA for closing surgical incisions and lacerations. Closure Medical's products provided a needle-free, microbial-barrier alternative to traditional sutures and staples, significantly advancing the field of wound management. In 2005, the company was acquired by Johnson & Johnson for approximately $370 million and was subsequently integrated into the Ethicon division. Today, the technologies developed by Closure Medical remain integral to Ethicon's market-leading portfolio of wound closure and surgical sealant products.